UCLA study first to image concussion-related abnormal brain proteins in retired players: http://newsroom.ucla.edu/portal/ucla/ucla-researchers-first-to-image-242445.aspx

PET imaging of neuropathology in tauopathies: progressive supranuclear palsy: http://www.ncbi.nlm.nih.gov/pubmed/23579330

Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging: http://www.ncbi.nlm.nih.gov/pubmed/23568102

PET of brain amyloid and tau in mild cognitive impairment: http://www.ncbi.nlm.nih.gov/pubmed/?term=small+gw+tau+amyloid+n+engl+j+med

Neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities: http://www.ncbi.nlm.nih.gov/pubmed/?term=fddnp+x-ray+crystallography

UCLA brain-imaging technique predicts who will suffer cognitive decline over time: http://newsroom.ucla.edu/portal/ucla/ucla-imaging-technique-predicts-220856.aspx

Imaging technique identifies plaques, tangles in brains of severely depressed older adults: http://newsroom.ucla.edu/portal/ucla/imaging-technique-identifies-plaques-213580.aspx

Assessment technique lets scientists see brain aging before symptoms appear: http://newsroom.ucla.edu/portal/ucla/new-ucla-imaging-technique-coupled-75584.aspx

Automated analysis in FDDNP PET: Validation through classification of Alzheimer’s disease patients: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310148/

Self-reported memory impairment and brain PET of amyloid and tau: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350563/

Multimodal Imaging of Alzheimer pathophysiology in the brain’s default mode network: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100676/

[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: Effects of aging, in vivo blockade, and anti-Aβ antibody treatment: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144750/

Voxel-based analysis of Alzheimer’s disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG: http://www.ncbi.nlm.nih.gov/pubmed/20385246

The merits of FDDNP-PET imaging in Alzheimer’s disease: http://www.ncbi.nlm.nih.gov/pubmed/21971458

Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693405/

UCLA researchers invent first technique to image Alzheimer’s onset: http://newsroom.ucla.edu/portal/ucla/UCLA-Researchers-Invent-First-Technique-2944.aspx